Effect of chemotherapy on the four diagnostic information of traditional Chinese medicine in lung cancer patients: a protocol for prospective cohort study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069031

Enrollment

Unknown

Registered

2023-03-05

Start date

2023-03-05

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Chemotherapy cohort:none

None-chemotherapy cohort:none

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patients meet the pathological diagnostic criteria for lung cancer; ? Age> 18 years old, gender is not limited; ? Patients can complete at least one cycle of treatment after enrollment; ? Patients are receiving or about to receive antitumor therapy; ? Voluntarily join the clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? Laboratory, electrocardiogram and other examinations indicate that there are contraindications to treatment; ? Patients with other primary malignant tumors; ? Women who are pregnant or lactating; ? There is a barrier to language communication and the content of the questionnaire cannot be completed.

Design outcomes

Primary

Measure	Time frame
Tongue image parameters;	—

Secondary

Measure	Time frame
Tongue infrared thermography;Infrared thermography of the face;TCM pulse diagnostic information;TCM symptom points;TCM syndrome type;	—

Countries

China

Contacts

Public ContactZhao hanqing

zhhqtt@163.com17325223981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026